Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 307

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 307
---
-Funded
Warrants do not have the rights or privileges of holders of our Common Stock, including any voting rights, until they exercise their
Pre-Funded Warrants.

Offered Common Warrants

The following summary of
certain terms and provisions of the Offered Common Warrants that are being offered hereby is not complete and is subject to, and qualified
in its entirety by, the provisions of the Offered Common Warrant, the form of which is filed as an exhibit to the registration statement
of which this prospectus forms a part. Prospective investors should carefully review the terms and provisions of the form of Offered
Common Warrant for a complete description of the terms and conditions of the Offered Common Warrants.

We are offering 2,551,020
Offered Common Warrants to purchase an aggregate of 2,551,020 shares of our Common Stock.

Each Offered Common Warrant
will have an exercise price per share of $1.96 and will be immediately exercisable beginning on the effective date of stockholder approval
of the issuance of the shares upon exercise of the Offered Common Warrants (the “Warrant Stockholder Approval”). The Offered
Common Warrants will expire on the 5-year anniversary of the Warrant Stockholder Approval.

The Offered Common Warrants
will be exercisable in whole or in part by delivering to the Company a completed instruction form for exercise and complying with the
requirements for exercise set forth in the Offered Common Warrant. Payment of the exercise price may be made in cash, in which case the
holder would receive upon such exercise the net number of shares of Common Stock determined according to the formula set forth in the
Offered Common Warrants.

No Fractional Shares

No fractional shares or
scrip representing fractional shares shall be issued upon the exercise of the Offered Common Warrants. As to any fraction of a share
which the holder would otherwise be entitled to purchase upon such exercise, the number of shares of Common Stock to be issued shall
be rounded up to the nearest whole number.

<div align='center'>180</div>

Exercise Limitation

In general, a holder will
not have the right to exercise any portion of an Offered Common Warrant if the holder (together with its Attribution Parties (as defined
in the Offered Common Warrant)) would beneficially own in excess of 4.99% or 9.99%, at the election of the holder, of the number of shares